Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
$9.36
+1.8%
$9.06
$1.75
$12.81
$193.27M1.3225,309 shs88,253 shs
Dominion Energy Inc. stock logo
D
Dominion Energy
$68.76
+0.3%
$69.05
$55.85
$72.99
$60.48B0.655.82 million shs1.95 million shs
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$1.09
+21.1%
$1.03
$0.56
$2.98
$89.67M1.522.43 million shs12.17 million shs
Slate Office REIT stock logo
SOT
Slate Office REIT
C$0.00
C$0.00
C$0.00
N/AN/AN/AN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
-0.05%-2.77%+16.33%-13.61%+190.33%
Dominion Energy Inc. stock logo
D
Dominion Energy
+0.78%+2.72%-3.89%+10.88%+10.49%
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
+16.90%+33.59%-22.41%-30.76%-47.05%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
$9.36
+1.8%
$9.06
$1.75
$12.81
$193.27M1.3225,309 shs88,253 shs
Dominion Energy Inc. stock logo
D
Dominion Energy
$68.76
+0.3%
$69.05
$55.85
$72.99
$60.48B0.655.82 million shs1.95 million shs
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$1.09
+21.1%
$1.03
$0.56
$2.98
$89.67M1.522.43 million shs12.17 million shs
Slate Office REIT stock logo
SOT
Slate Office REIT
C$0.00
C$0.00
C$0.00
N/AN/AN/AN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
-0.05%-2.77%+16.33%-13.61%+190.33%
Dominion Energy Inc. stock logo
D
Dominion Energy
+0.78%+2.72%-3.89%+10.88%+10.49%
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
+16.90%+33.59%-22.41%-30.76%-47.05%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
1.00
SellN/AN/A
Dominion Energy Inc. stock logo
D
Dominion Energy
2.20
Hold$68.00-1.11% Downside
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
2.75
Moderate Buy$3.17190.52% Upside
Slate Office REIT stock logo
SOT
Slate Office REIT
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest INO, AP, D, and SOT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
DowngradeSell (D-)Sell (E+)
8/13/2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
Reiterated RatingNeutral
8/13/2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
UpgradeHoldPositive$1.80 ➝ $3.00
8/13/2026
Dominion Energy Inc. stock logo
D
Dominion Energy
Lower Price TargetHold$68.00 ➝ $66.00
8/12/2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
UpgradeHoldStrong-Buy
8/11/2026
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
DowngradeSell (D+)Sell (D)
8/3/2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
Reiterated RatingOverweight$4.00
7/29/2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
UpgradeSell (E+)Sell (D-)
7/28/2026
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
UpgradeSell (D)Sell (D+)
7/22/2026
Dominion Energy Inc. stock logo
D
Dominion Energy
Boost Price TargetMarket Perform$64.00 ➝ $70.00
7/14/2026
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
DowngradeSell (D+)Sell (D)
(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
$428.04M0.45$0.95 per share9.82$2.36 per share3.96
Dominion Energy Inc. stock logo
D
Dominion Energy
$16.51B3.66$6.70 per share10.26$37.09 per share1.85
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$60K1,494.57N/AN/A$0.36 per share3.03
Slate Office REIT stock logo
SOT
Slate Office REIT
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
-$66.07M-$2.93N/AN/AN/A-13.84%-3.40%-0.38%N/A
Dominion Energy Inc. stock logo
D
Dominion Energy
$3.00B$2.8723.9618.05N/A13.98%9.62%2.64%10/30/2026 (Estimated)
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$84.95M-$1.45N/AN/AN/AN/A-600.31%-69.64%N/A
Slate Office REIT stock logo
SOT
Slate Office REIT
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest INO, AP, D, and SOT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$0.2167-$0.07+$0.1467-$0.07$0.53 millionN/A
8/11/2026Q2 2026
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
$0.08$0.07-$0.01$0.07$84.90 million$97.90 million
7/31/2026Q2 2026
Dominion Energy Inc. stock logo
D
Dominion Energy
$0.6810$0.79+$0.1090$0.37$4.04 billion$4.48 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
$0.363.85%N/AN/A N/A
Dominion Energy Inc. stock logo
D
Dominion Energy
$2.673.88%-5.00%93.03%N/A
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
N/AN/AN/AN/AN/A
Slate Office REIT stock logo
SOT
Slate Office REIT
N/AN/AN/AN/AN/A

Latest INO, AP, D, and SOT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
Dominion Energy Inc. stock logo
D
Dominion Energy
quarterly$0.66753.78%9/4/20269/4/20269/20/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
2.42
1.75
1.01
Dominion Energy Inc. stock logo
D
Dominion Energy
1.43
0.81
0.64
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
N/A
1.04
1.04
Slate Office REIT stock logo
SOT
Slate Office REIT
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
49.16%
Dominion Energy Inc. stock logo
D
Dominion Energy
73.04%
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
26.79%
Slate Office REIT stock logo
SOT
Slate Office REIT
N/A

Insider Ownership

CompanyInsider Ownership
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
23.48%
Dominion Energy Inc. stock logo
D
Dominion Energy
0.12%
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
1.70%
Slate Office REIT stock logo
SOT
Slate Office REIT
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Ampco-Pittsburgh Corporation stock logo
AP
Ampco-Pittsburgh
1,43220.66 million15.55 millionOptionable
Dominion Energy Inc. stock logo
D
Dominion Energy
15,200879.53 million878.47 millionOptionable
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
32082.27 million80.87 millionOptionable
Slate Office REIT stock logo
SOT
Slate Office REIT
27,700N/AN/ANot Optionable

Recent News About These Companies

When the Price of (SOT.DB.A) Talks, People Listen
True North: Strong Leasing Quarter Reduces Risk
Slate Retail REIT Trust Units -U-
Slate Office REIT managers, directors resign
Slate Office REIT (SOT-UN.TO)
Closing Bell: Slate Office REIT flat on Tuesday (SOT-UN)
Slate Office REIT (SOT_u)
Slate Office REIT (SOT.UN) Receives a Hold from RBC Capital

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Ampco-Pittsburgh stock logo

Ampco-Pittsburgh NYSE:AP

$9.36 +0.17 (+1.80%)
Closing price 03:59 PM Eastern
Extended Trading
$9.34 -0.02 (-0.21%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ampco-Pittsburgh Corporation, together with its subsidiaries, engages in manufacture and sale of specialty metal products and customized equipment to commercial and industrial users worldwide. The company operates through Forged and Cast Engineered Products (FCEP); and Air and Liquid Processing (ALP) segments. The FCEP segment produces forged hardened steel rolls, cast rolls and, forged engineered products that are used in cold rolling mills by producers of steel, aluminum, and other metals; cast rolls for hot strip mills, medium/heavy section mills, roughing mills, and plate mills; and forged engineered products for narrow and wide strip and aluminum mills, back-up rolls for narrow strip mills, and leveling rolls and shafts. The ALP segment produces custom-engineered finned tube heat exchange coils and related heat transfer products for various industries, including OEM/commercial, nuclear power generation, and industrial manufacturing; custom-designed air handling systems for institutional, pharmaceutical, and general industrial building markets; and manufacture centrifugal pumps for the fossil fueled power generation, marine defense, and industrial refrigeration industries. Ampco-Pittsburgh Corporation was incorporated in 1929 and is headquartered in Carnegie, Pennsylvania.

Dominion Energy stock logo

Dominion Energy NYSE:D

$68.76 +0.22 (+0.32%)
Closing price 03:59 PM Eastern
Extended Trading
$68.61 -0.15 (-0.22%)
As of 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Dominion Energy, Inc. produces and distributes energy in the United States. It operates through three operating segments: Dominion Energy Virginia, Dominion Energy South Carolina, and Contracted Energy. The Dominion Energy Virginia segment generates, transmits, and distributes regulated electricity to approximately 2.8 million residential, commercial, industrial, and governmental customers in Virginia and North Carolina. The Dominion Energy South Carolina segment generates, transmits, and distributes electricity to approximately 0.8 million customers in the central, southern, and southwestern portions of South Carolina; and distributes natural gas to approximately 0.4 million residential, commercial, and industrial customers in South Carolina. The Contracted Energy segment is involved in the nonregulated long-term contracted renewable electric generation and renewable natural gas facility. As of December 31, 2023, the company's portfolio of assets included approximately 29.5 gigawatt of electric generating capacity; 10,600 miles of electric transmission lines; 79,300 miles of electric distribution lines; and 94,800 miles of gas distribution mains and related service facilities. The company was formerly known as Dominion Resources, Inc. Dominion Energy, Inc. was incorporated in 1983 and is headquartered in Richmond, Virginia.

Inovio Pharmaceuticals stock logo

Inovio Pharmaceuticals NASDAQ:INO

$1.09 +0.19 (+21.10%)
Closing price 04:00 PM Eastern
Extended Trading
$1.08 -0.01 (-1.01%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Slate Office REIT stock logo

Slate Office REIT TSE:SOT

The Southern Company, through its subsidiaries, engages in the generation, transmission, and distribution of electricity. It operates through Gas Distribution Operations, Gas Pipeline Investments, Wholesale Gas Services, and Gas Marketing Services segments. The company also develops, constructs, acquires, owns, and manages power generation assets, including renewable energy projects and sells electricity in the wholesale market; and distributes natural gas in Illinois, Georgia, Virginia, and Tennessee, as well as provides gas marketing services, wholesale gas services, and gas pipeline investments operations. In addition, it owns and/or operates 30 hydroelectric generating stations, 24 fossil fuel generating stations, three nuclear generating stations, 13 combined cycle/cogeneration stations, 45 solar facilities, 15 wind facilities, one fuel cell facility, and four battery storage facility; and constructs, operates, and maintains 76,289 miles of natural gas pipelines and 14 storage facilities with total capacity of 157 Bcf to provide natural gas to residential, commercial, and industrial customers. The company serves approximately 8.7 million electric and gas utility customers. Further, the company offers digital wireless communications and fiber optics services. The Southern Company was incorporated in 1945 and is headquartered in Atlanta, Georgia.